Invesco Private Capital - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.

Quarter-by-quarter ownership
Invesco Private Capital ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$808,000
-1.1%
79,539
-38.6%
0.22%
-35.4%
Q4 2018$817,000
-52.2%
129,5390.0%0.34%
-46.1%
Q3 2018$1,710,000
-25.3%
129,539
-47.9%
0.63%
-21.6%
Q2 2018$2,289,000
+36.7%
248,823
-27.2%
0.81%
+25.4%
Q1 2018$1,675,000
+73.0%
341,8840.0%0.64%
+113.6%
Q4 2017$968,000
-12.7%
341,884
-9.0%
0.30%
-3.5%
Q3 2017$1,109,000
-6.3%
375,7840.0%0.31%
-21.6%
Q2 2017$1,184,000
-22.3%
375,784
-1.3%
0.40%
+38.1%
Q1 2017$1,523,000
-50.6%
380,784
-5.0%
0.29%
-57.1%
Q4 2016$3,085,000
-7.7%
400,677
-2.9%
0.67%
-22.8%
Q3 2016$3,341,000
+29.7%
412,479
-5.5%
0.87%
+60.3%
Q2 2016$2,575,000
-15.6%
436,3840.0%0.54%0.0%
Q1 2016$3,050,000
-13.1%
436,3840.0%0.54%
-18.4%
Q4 2015$3,509,000
-4.5%
436,384
-1.9%
0.67%
-12.4%
Q3 2015$3,673,000
-28.4%
444,6550.0%0.76%
+17.4%
Q2 2015$5,127,000
-32.8%
444,6550.0%0.65%
-31.6%
Q1 2015$7,626,000
-13.2%
444,6550.0%0.95%
-6.5%
Q4 2014$8,782,000444,6551.01%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 266,961$9,119,38810.70%
COMMODORE CAPITAL LP 1,845,000$63,025,2007.37%
TLS Advisors LLC 32,956$1,1264.56%
Altium Capital Management LP 228,000$7,788,4804.06%
Paradigm Biocapital Advisors LP 1,491,835$50,961,0843.46%
GREAT POINT PARTNERS LLC 500,001$17,080,0343.11%
DAFNA Capital Management LLC 280,538$9,583,1782.98%
Nan Fung Group Holdings Ltd 106,680$3,644,1892.95%
Affinity Asset Advisors, LLC 300,438$10,262,9622.89%
Avoro Capital Advisors LLC 4,900,000$167,384,0002.61%
View complete list of XENON PHARMACEUTICALS INC shareholders